Is Too Much Intervention Recommended in the ACP Osteoporosis Treatment Guidelines?

  1. Amir Qaseem, MD, PhD, MHA;
  2. Paul Shekelle, MD, PhD; and
  3. Douglas K. Owens, MD, MS
  1. From American College of Physicians, Philadelphia, PA 19106; Veterans Affairs Greater Los Angeles Healthcare System and RAND, Santa Monica, CA 90401; and Stanford University, Stanford, CA 94305.

    IN RESPONSE:

    We thank Dr. Alonso-Coello and colleagues for their comments regarding the ACP's recent guideline on pharmacologic treatment of osteoporosis. The Fracture Risk Assessment Tool (FRAX) may be a useful instrument for estimating an individual patient's risk for fracture, and we noted in our guideline that physicians may use such models to help guide their decisions. However, evidence from randomized, controlled trials showing the …

    [Full Text of this Article]

    Related Article

    • Clinical Guidelines:Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians
      • Amir Qaseem,
      • Vincenza Snow,
      • Paul Shekelle,
      • Robert Hopkins, Jr.,
      • Mary Ann Forciea,
      • Douglas K. Owens,
      • and for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians
      Ann Intern Med September 16, 2008 149:404-415
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med February 17, 2009 vol. 150 no. 4 286-287
    1. » Excerpt
    2. Full Text
    3. Full Text (PDF)
    4. Related Article

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 1, 2009, 151 (11)
    1. Alert me to current issues